Home › Funds › Aristotle Capital Management, LLC › EW

Aristotle Capital Management, LLC position in EW

EDWARDS LIFESCIENCES CORP · Health Care

Aristotle Capital Management, LLC reported holding 8,117,608 shares of EW (EDWARDS LIFESCIENCES CORP) in its Q3 2026 13F filing — a position valued at US$700.7M, representing 1.74% of its reported portfolio and ranking #25 among its reported holdings. Aristotle Capital Management, LLC has disclosed EW holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)8.12M sh
Reported value held$700.72M
Portfolio Weight1.74%
First reportedQ2 2026
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Aristotle Capital Management, LLC's EW position evolved

Aristotle Capital Management, LLC first disclosed a stake in EW in Q2 2026 at 8,665,712 shares (US$783.9M). Across 2 filings, Aristotle Capital Management, LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 8,117,608 shares valued at US$700.7M — a reduction of -548,104 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q2 2026 8.67M $783.91M New
Q3 2026 8.12M $700.72M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About EW and 13F data

EW (EDWARDS LIFESCIENCES CORP) is a Health Care company. 28 other funds we track also report a position in EW — the largest reported positions include Belvedere Trading LLC (US$25.63B), DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt (US$1.18B), Ninety One UK Ltd (US$1.03B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EW

All EW fund holders →

FAQ

How long has Aristotle Capital Management, LLC held EW?

Aristotle Capital Management, LLC has disclosed EW holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Aristotle Capital Management, LLC's current position in EW?

As of Q3 2026, Aristotle Capital Management, LLC holds 8.12M shares of EW (EDWARDS LIFESCIENCES CORP), valued at $700.72M, representing 1.74% of its reported portfolio and ranking #25.

Has Aristotle Capital Management, LLC been buying or selling EW?

In the latest 13F filing (Q3 2026), Aristotle Capital Management, LLC reduced its position in EW.

Which other funds hold EW?

Other major institutional holders of EW include Belvedere Trading LLC, DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt, Ninety One UK Ltd, among 28 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.